Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

InnoPharma

InnoPharma
2005 FOUNDED
M&A STATUS
81-90 EMPLOYEES
M&A LATEST DEAL TYPE
$360M LATEST DEAL AMOUNT
Description

Developer of complex generic and innovative specialty pharmaceutical/bio-pharmaceutical products in injectable and ophthalmic dosage forms. The company has a broad portfolio of products under development, with formulations including, suspension, lyophilized, emulsions, liposomes, micelles and lipid complexes.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
  • 10 Knightsbridge Road
  • Piscataway Township, NJ 08854
  • United States

+1 (732) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore InnoPharma’s full profile, request a free trial.

InnoPharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-Sep-2014 $360M 0000 00000 Completed Product Development
3. Debt - General 13-Nov-2013 0000 0000 Completed Product Development
2. Debt - General 07-Jun-2012 $8M $23M Completed Product Development
1. Early Stage VC (Series A) 01-Dec-2011 $15M $15M 000.00 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

InnoPharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00 00 00 00 0.000
To view this company’s complete Cap Table, request access »

InnoPharma Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sandoz Corporate Backed or Acquired Holzkirchen, Germany 00000 00000000000
00000 000000000000 Corporate Backed or Acquired Franklin Township, NJ 000 000000&0
00000000 Corporate Backed or Acquired Dublin, Ireland 0000 000000&0
0000 000000 Private Debt Financed Monmouth Junction, NJ 000 000000000 00
00000000000 000000 Private Equity-Backed Mexico City, Mexico 000.00 0000000000 000.00
To view this company’s complete list of competitors, request access »

InnoPharma Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Athyrium Capital Management Asset Manager Minority 000 0000 000000 0
Thomas McNerney & Partners Venture Capital Minority 000 0000 000000 0

InnoPharma Executive Team (5)

Name Title Board
Seat
Contact
Info
John Deighan Chief Financial Officer
Satish Pejaver Ph.D Chief Scientific Officer
Navneet Puri Ph.D Chief Executive Officer, Board Member, Co-Founder & President
Sriram Ramanathan Chief Operating Officer & Co-Founder

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

InnoPharma Board Members (4)

Name Representing Role Since Contact
Info
Peter Werth Self Board Member 000 0000
Raman Kapur Self Board Member 000 0000

2 Former Board Members

You’re viewing 2 of 4 board members. Get the full list »